Cannella, L., Breccia, M., Loglisci, G., Federico, V., Santopietro, M., & Alimena, G. (2010). Safety and efficacy of nilotinib in chronic phase chronic myeloid leukemia in a patient with Wolf-Parkinson-White disease and hematological resistance after suboptimal response to imatinib at six months. Acta Oncologica, 49(3), 399–400. https://doi.org/10.3109/02841860903521129